Abbott (NYSE:ABT) announces
that the FDA has issued Emergency Use Authorization for its molecular
test that can detect a positive coronavirus diagnosis in as little as
five minutes and a negative result in 13 minutes.
The test runs on Abbott’s point-of-care ID Now
platform, a portable instrument that can be used in almost any
healthcare setting.
The ID NOW COVID-19 tests will be available next
week, and Abbott expects to ramp up manufacturing to deliver 50,000
tests per day by April 1.
https://seekingalpha.com/news/3556045-abbott-launches-five-minute-coronavirus-test
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.